[Male sexual dysfunction involving penile erection, emission and ejaculation].
Shiina
Hiroaki
H
Department of Urology, Shimane University School of Medicine.
Igawa
Mikio
M
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000527:Alprostadil / Q000008:administration & dosage; D004542:Ejaculation; D007172:Erectile Dysfunction / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D010410:Penile Erection / Q000502:physiology / Q000523:psychology; D019935:Penile Implantation; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011613:Psychotherapy; D011687:Purines; D027724:Reproductive Techniques, Assisted; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D000068677:Sildenafil Citrate; D013450:Sulfones
D015106:3',5'-Cyclic-GMP Phosphodiesterases; D000317:Adrenergic alpha-Antagonists; D000527:Alprostadil; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D017367:Selective Serotonin Reuptake Inhibitors; D000068677:Sildenafil Citrate; D013450:Sulfones